The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex complicated synthetic process. Early routes focused on peptide section coupling, utilizing solid-phase https://margienmzc697583.blogpayz.com/40991359/synthesis-and-investigation-implementations-of-retatrutide